MULT1-Encoding DNA Alleviates Schistosomiasis-Associated Hepatic Fibrosis via Modulating Cellular Immune Response
Lu Yang,Li Sun,Yalan Cao,Qi Wang,Anni Song,Ru Zhu,Wenqi Liu,Shengjun Lu
DOI: https://doi.org/10.2147/jir.s354224
IF: 4.5
2022-07-16
Journal of Inflammation Research
Abstract:Lu Yang, 1, &ast Li Sun, 1 Yalan Cao, 1 Qi Wang, 1, 2 Anni Song, 1 Ru Zhu, 1 Wenqi Liu, 1 Shengjun Lu 1, &ast 1 Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Department of Histology and Embryology, School of Basic Medicine, Guizhou Medical University, Guiyang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shengjun Lu; Wenqi Liu, Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China, Tel +86 15307159688 ; +86 13886014791, Fax +86-27-83692608, Email ; Purpose: In schistosomiasis-associated hepatic fibrosis, the role of murine UL16-binding protein-like transcript 1 (MULT1), the strongest ligand of natural killer group 2-member D receptor (NKG2D), remains unclear. Here, Schistosoma japonicum -infected mice administered with MULT1-encoding DNA were used to test MULT1 as a potential therapy for schistosomiasis-associated hepatic fibrosis and explore relevant mechanisms. Materials and Methods: A recombinant plasmid encoding MULT1 (p-rMULT1) was constructed and administered to Schistosoma japonicum -infected BALB/c mice via hydrodynamic tail vein injection. Egg granulomas in liver, hepatic fibrosis biomarkers and levels of cytokines were investigated. Comparisons of CD4+ T, CD8+ T, NK and NKT proportions as well as their phenotype were performed not only between Schistosoma infected, p-rMULT1 treated group and Schistosoma infected, backbone plasmid pEGFP-N1 treated group but also between infected, nontreated group and health control group. Results: Reduced area of granuloma formation and fibrosis around single eggs, downregulated expression of collagen I, α-smooth muscle actin, TGF-β and IL-10, and upregulated expression of IFN-γ, were observed in the livers of p-rMULT1 treated mice. p-rMULT1 treatment improved Schistosoma infection impacted immune microenvironment by modulating proportion of CD4 + T CD8 + T, natural killer (NK) and NKT cells, enhancing expression of NKG2D, in lymphocytes, and augmenting IFN-γ secretion by CD4 + T, CD8 + T, NK and NKT cells, as well as partially reversing some other phenotype changes of lymphocytes. Conclusion: To the best of our knowledge, we provided the first in vivo evidence that MULT1 is a favorable anti-fibrosis factor in the context of schistosomiasis. The inhibitory effect of MULT1 overexpression on schistosomiasis associated with hepatic fibrosis may result from augmenting the proportion and function of NKG2D-expressing immune cells, and from enhancing NK- and T-cell activation, as well as regulating the helper T (Th)1/Th2 balance. Keywords: schistosomiasis, NKG2D, liver fibrosis, IFN-γ, natural killer cells, T lymphocytes Schistosomiasis is a helminthic infectious disease, affecting ~258 million individuals in 78 countries. 1,2 Schistosoma mansoni and Schistosoma japonicum infection can cause severe liver fibrosis induced by eggs trapped in the liver. At 4–6 weeks after being infected by S. japonicum , patients enter the chronic infection stage, in which the eggs are excreted and partially deposited into the liver. The deposited eggs release soluble egg antigens, which trigger extensive infiltration by monocytes, eosinophils, neutrophils and lymphocytes, leading to granulomatous immune-pathogenesis lesion. 3,4 Activated hepatic stellate cells (HSCs) during the persistent lesion transformed into fibroblasts to help heal and produce large amount of extracellular matrix, including collagen fibers, more than that can be degenerated by tissue proteinase, resulting in fibrosis at the granuloma site. 3,4 Helper T (Th) 2 immune response driven by IL-4, IL-5, IL-10 and IL-13 is the most prominent immune response observed during liver fibrosis. 5–7 IL-4 and IL-5 antibody treatment can significantly suppress liver fibrosis in mice. 8 In IL-4 gene-deficient mice, absolute IL-4 absence makes acute lethal inflammation occur after schistosomiasis, accompanied by severe hepatic and intestinal damage. 9,10 IL-13 stimulates the activation and differentiation of HSCs into fibroblasts and facilitates fibrosis. 11,12 Evidence both from patient and from mouse model indicates that IL-13 is a strong accelerator for the progress of liver fibrosis after Schistosoma infection. 13,14 IL-4, I -Abstract Truncated-
immunology